Prostate Health Articles & Analysis
14 news found
Across North America, September is recognized as Prostate Cancer Awareness Month by healthcare experts, advocates and organizations concerned with men's prostate health. miR Scientific's goal is to introduce #CanDoBlue into men's health conversations in Canada, Israel, Japan, the U.S., Puerto Rico, Singapore, and other global ...
In addition to its oncology drug pipeline, Qualigen has an established diagnostics business which manufactures and distributes proprietary and highly accurate rapid blood testing systems to physician offices and small hospitals for the management of prostate cancer and other diseases and health conditions. For more information about Qualigen Therapeutics, Inc., ...
Stephen Neidle Session Title: New Chemotherapy Agents Session Date and Time: Wednesday Apr 13, 2022 9:00 AM - 12:30 PM CDT Abstract Number: 4068 Title: “The potent quadruplex-binding compound SOP1812 shows potent anti-proliferative activity in a prostate cancer cell panel and anti-tumor activity in an in vivo model of metastatic ...
In addition to its oncology drug pipeline, Qualigen has an established diagnostics business which manufactures and distributes proprietary and highly accurate rapid blood testing systems to physician offices and small hospitals for the management of prostate cancer and other diseases and health conditions. For more information about Qualigen Therapeutics, Inc., ...
In addition to its oncology drug pipeline, Qualigen has an established diagnostics business which manufactures and distributes proprietary and highly accurate rapid blood testing systems to physician offices and small hospitals for the management of prostate cancer and other diseases and health conditions. For more information about Qualigen Therapeutics, Inc., ...
In addition to its oncology drug pipeline, Qualigen has an established diagnostics business which manufactures and distributes proprietary and highly accurate rapid blood testing systems for the management of prostate cancer and other diseases and health conditions. Qualigen’s management has significant experience in drug and medical device development, ...
In addition to an attractive oncology drug pipeline, Qualigen has an established diagnostics business which manufactures and distributes proprietary and highly accurate rapid testing systems for the management of prostate cancer and other diseases and health conditions. Qualigen is managed by a team of seasoned experts in drug and medical device development, ...
The Annual Prostate Cancer Awareness Day (PCAD) at the Massachusetts State House was established in September 2009 by the AdMeTech Foundation, a non-profit organization. This event resulted in the rapidly growing recognition of prostate cancer as a public health priority and support for increased research funding for the advancement of early ...
Recently the 21-year Major League veteran divulged that earlier this year he was diagnosed with and successfully treated for prostate cancer. Today Ripken, 60, is leading a national effort with Exosome Diagnostics to build education and awareness of the ExoDx ™ Prostate test, encourage men to proactively take action and be aware of their ...
Cleveland Diagnostics, Inc., a clinical-stage company focused on developing next-generation diagnostic tests for the early detection of cancers, announced today that it has received FDA Breakthrough Device Designation for the IsoPSA® Assay, a novel prostate cancer diagnostic test. Published studies from multicenter prospective clinical trials suggest that the non-invasive, ...
Cleveland Diagnostics, Inc., a biotechnology company focused on developing next-generation diagnostics for the detection of cancers, today announced the online publication of interim results for an ongoing multi-center trial of the IsoPSA™ prostate cancer test in European Urology. The findings illustrate a significantly improved diagnostic accuracy over the current gold ...
Last year about 12 Intelexians united to grow mustaches for the month of November to help raise money for men’s health awareness. During that run we raised $2,500, a sum Intelex President and CEO Mark Jaine matched for a total of $5,000. ...
In addition to Intelexians raising $2,635 throughout the month of November to help support research for prostate cancer, President and CEO Mark Jaine also pledged that the company would match all donations made during Movember, bringing the grand total to $5,270! ...
For those who haven’t heard of Movember, it’s a campaign that raises funds and awareness for prostate cancer and is best credited for the majority of entertaining and unique moustaches you’ll see during the month of November. ...